Adaptimmune Therapeutics plc American Depositary Shares (ADAP) EBITDA (2015 - 2025)
Adaptimmune Therapeutics plc American Depositary Shares (ADAP) EBITDA from Jun 30, 2015 to Jun 30, 2025. The TTM Adaptimmune Therapeutics plc American Depositary Shares (ADAP) EBITDA is -$149M. You can adjust inflation or export chart.
Annual EBITDA
Quarterly EBITDA
Adaptimmune Therapeutics plc American Depositary Shares (ADAP) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +118.95% |
| 3 Years TTM | -4.51% |
| 5 Years TTM | +4.70% |
| 10 Years TTM | +29.62% |
| All Time TTM | +13.86% |
Annual EBITDA change of Adaptimmune Therapeutics plc American Depositary Shares (ADAP)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$71M | +50.75% |
| 2024 | -$47M | -63.72% |
| 2023 | -$130M | -17.73% |
| 2022 | -$158M | +2.14% |
| 2021 | -$155M | +25.17% |
| 2020 | -$124M | -4.26% |
| 2019 | -$129M | +79.88% |
| 2018 | -$72M | -4.69% |
| 2017 | -$75M | +8.24% |
| 2016 | -$70M | +257.93% |
| 2015 | -$19M | N/A |